perlecan (heparan sulfate proteoglycan 2)
| GO Term | Evidence Code | PMID |
|---|---|---|
| angiogenesis | ||
| response to hypoxia |
|
|
| positive regulation of endothelial cell proliferation | ||
| endochondral ossification | ||
| chondrocyte differentiation |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| basement membrane | ||
| Golgi lumen | ||
| extracellular matrix | ||
| collagen-containing extracellular matrix |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protease binding | ||
| calcium ion binding | ||
| protein binding | ||
| extracellular matrix structural constituent conferring compression resistance | ||
| collagen V binding |
| Gene Ontology |
|---|
| calcium ion binding |
| cell differentiation |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060770 | dextro-looped transposition of the great arteries | |
| DOID:0090005 | Schwartz-Jampel syndrome 1 | |
| DOID:0090032 | Silverman-Handmaker type dyssegmental dysplasia | |
| DOID:13481 | thanatophoric dysplasia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025